CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022	Jun. 30, 2021
Revenues:
Total revenues	$ 49,869	$ 38,078
Cost and operating expenses:
Cost of sales	626
Research and development	51,620	44,282
Selling, general and administrative	40,016	16,648
Total cost and operating expenses	92,262	60,930
Loss from operations	(42,393)	(22,852)
Investment income, net	2,169	54
Non-cash interest expense on liability related to the sale of future royalties and convertible senior notes	(853)	(1,249)
Other (expense) income, net	63	(98)
Net loss	$ (41,014)	$ (24,145)
Basic net loss per common share	$ (0.16)	$ (0.10)
Diluted net loss per common share			$ (0.34)	$ (0.32)
Basic weighted average common shares outstanding (in shares)	258,848	253,263
Diluted weighted average common shares outstanding (in shares)			253,263	199,365
Total comprehensive loss	$ (41,014)	$ (24,145)
License and milestone fees
Revenues:
Total revenues	15,031	30,892
Non-cash royalty revenue related to the sale of future royalties
Revenues:
Total revenues	4,839	6,428
Research and development support
Revenues:
Total revenues	455	$ 758
Product revenue, net
Revenues:
Total revenues	$ 29,544